Ongericimab (Anti-PCSK9)
Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2987 |
Sku # | A2987-1mg*5 |
Pricing | 1mg*5, $1690.00 |